Towards Healthcare
Osteoarthritis Therapeutics Market to Lead USD 24.52 Bn by 2034

Osteoarthritis Therapeutics Market Expanding with Biologics

Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of the market in the near future. North America led the global market owing to the high prevalence of osteoarthritis in the region.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The osteoarthritis therapeutics market is valued at USD 10.89 billion in 2025 and is on track to reach USD 24.52 billion by 2034, witnessing a steady CAGR of 9.45% during the forecast span.

North America is leading the osteoarthritis therapeutics market share by 41% due to the rising prevalence of osteoarthritis, advancements in osteoarthritis treatments, and the presence of major key players.

The osteoarthritis therapeutics market includes five segments including by drug class, by route of administration, by joint type, by distribution channel, and by region.

Key trends include the advanced injectable formulations & viscosupplementation, focus on research and development, and adoption of inorganic growth strategies.

Osteoarthritis Research Society International (OARSI), Personalized Medicine Coalition, SOAR - Society for Osteoarthritis Research, Government of Canada, OAFI Foundation: International Osteoarthritis Foundation, Food and Drug Administration, Arthritis Foundation, clinicaltrials.gov, American College of Rheumatology, GOV.UK and OARSI-Osteoarthritis Research Society International among others.
Any Questions